Clinical trial
Geodon (Ziprasidone) for Posttraumatic Stress Disorder
NCT00208208 · Creighton University, Other · Completed
Key facts
| NCT number | NCT00208208 |
|---|---|
| Title | Geodon (Ziprasidone) for Posttraumatic Stress Disorder |
| Official title | Geodon (Ziprasidone) for Posttraumatic Stress Disorder |
| Lead sponsor | Creighton University, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Posttraumatic Stress Disorder, Post-Traumatic Stress Disorder, PTSD |
| Intervention type | Drug |
| Interventions | Ziprasidone |
| Enrollment | 80 |
| Start date | Dec 1, 2002 |
| Completion | Apr 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Sep 15, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: